recombinant LH

also known as LH

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT02201914 Background	Jan → Oct 2014	—	Bioroma	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	recombinant LH	“patients receive clomiphene citrate 100 mg daily starting on day 2 for 5 days and 450 IU recombinant FSH and 225 IU recombinant LH daily starting on day 5; Cetrorelix 0,25 mg...” NCT02201914 ↗
Known as	LH	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02201914 ↗
Modality	Protein / enzyme biologic	“225 IU recombinant LH” NCT02201914 ↗